CAS: 1620992-67-7
Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
---|---|---|---|---|
4-Methyl-N-[5-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]-4-thiophen-2-yl-1,3-thiazol-2-yl]cyclohexane-1-carboxamide REF: 3D-VPC99267CAS: 1620992-67-7 | Min. 95% | A consultar | Ter 07 Jan 25 | |
GPR81 agonist 1 REF: TM-T62656CAS: 1620992-67-7 | 99.68% | 127,00 €~2.229,00 € | Ter 14 Jan 25 |
4-Methyl-N-[5-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]-4-thiophen-2-yl-1,3-thiazol-2-yl]cyclohexane-1-carboxamide
CAS:1620992-67-7
4-Methyl-N-[5-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]-4-thiophen-2-yl-1,3-thiazol-2-yl]cyclohexane-1-carboxamide is a high purity drug. It is a potent inhibitor of voltage gated potassium …
Fórmula:
C22H30N4O2S2
Pureza:
Min. 95%
Peso molecular:
446.6 g/mol
Ref: 3D-VPC99267
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar |
Entrega estimada em Estados Unidos, Terça-feira 7 de Janeiro de 2025
GPR81 agonist 1
CAS:1620992-67-7
GPR81 agonist 1 is a GPR81 agonist that improves glycaemic control in insulin-resistant mouse models …
Fórmula:
C22H30N4O2S2
Pureza:
99.68%
Cor e Forma:
Liquid
Peso molecular:
446.63
Ref: TM-T62656
1mg | 127,00 € | ||
5mg | 305,00 € | ||
10mg | 521,00 € | ||
25mg | 974,00 € | ||
50mg | 1.474,00 € | ||
1mL*10mM (DMSO) | 276,00 € |
Entrega estimada em Estados Unidos, Terça-feira 14 de Janeiro de 2025